Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Q&A: Time-restricted eating can have a 'meaningful impact' on metabolic syndrome
Time-restricted eating can improve the health of individuals with metabolic syndrome, who are on the precipice of type 2 diabetes, heart disease and other health complications, according to an expert.
GLP-1 medication access limited by care site, payer type, demographics
SAN ANTONIO — Access to GLP-1 medications is potentially impacted by care site, payer type and demographics, highlighting gaps in care that disproportionately affect certain patient subgroups, according to a presentation at ObesityWeek.
Log in or Sign up for Free to view tailored content for your specialty!
GLP-1 alternative well-tolerated, could lead to similar rate of weight loss
SAN ANTONIO — Petrelintide, a novel once-weekly amylin analog, was well-tolerated in a cohort of healthy people with overweight or obesity, while conferring up to 8.6% weight loss at 16 weeks, a speaker reported.
50% of teens have micronutrient deficiencies 10 years after weight-loss surgery
SAN ANTONIO — Half of adolescents had two or more micronutrient deficiencies 10 years after metabolic and bariatric surgery, with deficiencies more common after Roux-en-Y gastric bypass, according to a presentation at ObesityWeek.
Retatrutide linked to improved health-related quality of life plus weight loss
SAN ANTONIO — In patients with obesity, the novel triple receptor agonist retatrutide was associated with improvement in health-related quality of life vs. placebo, a speaker reported.
Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years
SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.
Weight-loss interventions ‘useful tool’ to improve PCOS symptoms
Women with polycystic ovary syndrome who initiated any weight-loss intervention saw improvements in some glycemic and hormonal measures as well as improved menstrual frequency, data from a meta-analysis show.
GLP-1s reduce incident hypertension risk for adolescents with obesity
SAN ANTONIO — In adolescents with obesity, GLP-1 receptor agonists were associated with lower risk for incident hypertension development 5 and 10 years after initiation vs. other anti-obesity medications, a speaker reported.
New agent may help halt weight gain caused by antipsychotic drug
SAN ANTONIO —An intestinal microsomal triglyceride transfer protein inhibitor reduced postprandial triglycerides and halted weight gain in patients treated with the antipsychotic olanzapine, according to results of a pilot study.
Sex, race, insurance type predict youth access to obesity drugs
SAN ANTONIO — Researchers identified several factors associated with likelihood of obesity drug prescription among youths, including female sex, higher obesity severity, having more comorbidities and older age, a speaker reported.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read